96 related articles for article (PubMed ID: 2804987)
1. Phase I trial of hepatic artery infusion of 5-iodo-2'-deoxyuridine and 5-fluorouracil in patients with advanced hepatic malignancy: biochemically based combination chemotherapy.
Remick SC; Benson AB; Weese JL; Willson JK; Ramirez G; Wirtanen GW; Alberti DB; Nieting LM; Tutsch KD; Fischer PH
Cancer Res; 1989 Nov; 49(22):6437-42. PubMed ID: 2804987
[TBL] [Abstract][Full Text] [Related]
2. Phase I clinical and pharmacological study of iododeoxyuridine and bleomycin in patients with advanced cancer.
Schilsky RL; Janisch L; Berezin F; Mick R; Vogelzang NJ; Ratain MJ
Cancer Res; 1993 Mar; 53(6):1293-6. PubMed ID: 7680282
[TBL] [Abstract][Full Text] [Related]
3. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.
Guthoff I; Lotspeich E; Fester C; Wallin I; Schatz M; Ehrsson H; Kornmann M
Anticancer Res; 2003; 23(6D):5203-8. PubMed ID: 14981990
[TBL] [Abstract][Full Text] [Related]
4. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M;
J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis.
Morgan RJ; Newman EM; Doroshow JH; McGonigle K; Margolin K; Raschko J; Chow W; Somlo G; Leong L; Tetef M; Shibata S; Hamasaki V; Carroll M; Vasilev S; Akman S; Coluzzi P; Wagman L; Longmate J; Paz B; Yen Y; Klevecz R
Cancer Res; 1998 Jul; 58(13):2793-800. PubMed ID: 9661893
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of 5-fluorouracil and dipyridamole administered by seventy-two-hour concurrent continuous infusion.
Remick SC; Grem JL; Fischer PH; Tutsch KD; Alberti DB; Nieting LM; Tombes MB; Bruggink J; Willson JK; Trump DL
Cancer Res; 1990 May; 50(9):2667-72. PubMed ID: 2328492
[TBL] [Abstract][Full Text] [Related]
7. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M
In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759
[TBL] [Abstract][Full Text] [Related]
8. Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer.
Qin B; Kato K; Mitsugi K; Nakamura M; Tanaka R; Baba E; Ariyama H; Kuroiwa T; Harada M; Nakano S
Cancer Chemother Pharmacol; 2006 Jan; 57(1):114-9. PubMed ID: 16001177
[TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints.
Reid T; Galanis E; Abbruzzese J; Sze D; Wein LM; Andrews J; Randlev B; Heise C; Uprichard M; Hatfield M; Rome L; Rubin J; Kirn D
Cancer Res; 2002 Nov; 62(21):6070-9. PubMed ID: 12414631
[TBL] [Abstract][Full Text] [Related]
10. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
[TBL] [Abstract][Full Text] [Related]
11. [A case of hepatocellular carcinoma responding to hepatic arterial infusion chemotherapy with low-dose cisplatin and 5-fluorouracil].
Takeda Y; Hasuike Y; Tsujinaka T
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1712-7. PubMed ID: 11708016
[TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
Kemeny NE; Niedzwiecki D; Hollis DR; Lenz HJ; Warren RS; Naughton MJ; Weeks JC; Sigurdson ER; Herndon JE; Zhang C; Mayer RJ
J Clin Oncol; 2006 Mar; 24(9):1395-403. PubMed ID: 16505413
[TBL] [Abstract][Full Text] [Related]
13. [Management after hepatectomy of colorectal cancer metastases to the liver--intrahepatic arterial infusion chemotherapy and repeated hepatectomy].
Takanishi K; Matsumoto J; Minami T
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1747-51. PubMed ID: 10560386
[TBL] [Abstract][Full Text] [Related]
14. Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer.
Kim JC; Kim HC; Lee KH; Yu CS; Kim TW; Chang HM; Ryu MH; Kim JH; Ha HK; Lee MG
J Gastroenterol Hepatol; 2006 Jun; 21(6):1026-35. PubMed ID: 16724990
[TBL] [Abstract][Full Text] [Related]
15. [Continuous hepatic arterial infusion chemotherapy with low-dose CDDP plus 5-FU for liver metastases from colorectal carcinoma].
Kohnoe S; Taketomi A; Morita M; Baba H; Matsuoka H; Seo Y; Saito T; Tomoda H
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1429-32. PubMed ID: 8854771
[TBL] [Abstract][Full Text] [Related]
16. [The 5-fluorouracil hepato-arterial infusion with oral UFT therapy for the hepatic and extra hepatic metastases of colorectal cancer].
Maruyama S; Maruyama M; Kato K; Koide A; Ohbu M; Hasegawa K; Takashima I; Ebuchi M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1743-5. PubMed ID: 15553701
[TBL] [Abstract][Full Text] [Related]
17. [Hepatic arterial infusion of low-dose leucovorin/5-FU chemotherapy for unresectable hepatic metastases from colorectal cancer].
Fujimoto T; Yoshimatsu K; Yokomizo H; Umehara A; Watanabe K; Ohtani T; Matsumoto A; Ohsawa G; Ishibashi K; Ogawa K
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1838-40. PubMed ID: 17212122
[TBL] [Abstract][Full Text] [Related]
18. [The treatment of liver metastases of colorectal tumors using intra-arterial fluorouracil via hepatic artery, administered with a completely implantable access system and a portable infusion pump].
van Groeningen CJ; Meyer S; Vermorken JB; Nieweg MB; Cuesta M; Pinedo HM
Ned Tijdschr Geneeskd; 1993 Oct; 137(40):2039-43. PubMed ID: 8413719
[TBL] [Abstract][Full Text] [Related]
19. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
Kemeny N; Eid A; Stockman J; Gonen M; Schwartz L; Tetzlaff E; Paty P
J Surg Oncol; 2005 Aug; 91(2):97-101. PubMed ID: 16028279
[TBL] [Abstract][Full Text] [Related]
20. Hepatic arterial infusion (HAI) of cisplatin and systemic fluorouracil in the treatment of unresectable colorectal liver metastases.
Mancini R; Tedesco M; Garufi C; Filippini A; Arcieri S; Caterino M; Pizzi G; Cortesi E; Spila A; Sperduti I; Cosimelli M
Anticancer Res; 2003; 23(2C):1837-41. PubMed ID: 12820466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
